Amphastar Pharmaceuticals PE Ratio 2012-2024 | AMPH

Current and historical p/e ratio for Amphastar Pharmaceuticals (AMPH) from 2012 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Amphastar Pharmaceuticals PE ratio as of November 20, 2024 is 12.61.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Amphastar Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-11-19 43.62 14.54
2024-09-30 48.53 $3.00 16.18
2024-06-30 40.00 $3.13 12.78
2024-03-31 43.91 $2.89 15.19
2023-12-31 61.85 $2.58 23.97
2023-09-30 45.99 $2.56 17.96
2023-06-30 57.47 $1.95 29.47
2023-03-31 37.50 $1.79 20.95
2022-12-31 28.02 $1.76 15.92
2022-09-30 28.10 $1.49 18.86
2022-06-30 34.79 $1.78 19.54
2022-03-31 35.90 $1.61 22.30
2021-12-31 23.29 $1.24 18.78
2021-09-30 19.01 $0.72 26.40
2021-06-30 20.16 $0.21 96.00
2021-03-31 18.32 $0.05 366.40
2020-12-31 20.11 $0.03 670.33
2020-09-30 18.75 $0.14 133.93
2020-06-30 22.46 $0.09 249.56
2020-03-31 14.84 $1.05 14.13
2019-12-31 19.29 $0.99 19.48
2019-09-30 19.83 $1.05 18.89
2019-06-30 21.11 $1.07 19.73
2019-03-31 20.43 $0.05 408.60
2018-12-31 19.90 $-0.13 0.00
2018-09-30 19.24 $-0.14 0.00
2018-06-30 15.26 $-0.19 0.00
2018-03-31 18.75 $-0.09 0.00
2017-12-31 19.24 $0.09 213.78
2017-09-30 17.87 $0.00 0.00
2017-06-30 17.86 $0.08 223.25
2017-03-31 14.50 $0.19 76.32
2016-12-31 18.42 $0.22 83.73
2016-09-30 18.97 $0.44 43.11
2016-06-30 16.12 $0.29 55.59
2016-03-31 12.00 $-0.01 0.00
2015-12-31 14.23 $-0.07 0.00
2015-09-30 11.69 $-0.29 0.00
2015-06-30 17.58 $-0.34 0.00
2015-03-31 14.96 $-0.22 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.097B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00